Login
GRAF Webinar on demand

Accelerating Drug Discovery: How GRAF Pangenomes Enable Enhanced Insights From Sequencing Data.

Uncover solutions to the pressing challenges in Next-Generation Sequencing (NGS) data analysis with Velsera. Join our upcoming webinar to address a pivotal pain point in genomics: reference bias. Learn how Velsera's GRAF solution tackles reference bias and seamlessly integrates with existing pipelines, lowering computational costs and elevating your NGS analysis efficiency.

During this session, attendees will gain an understanding of GRAF's capabilities, demystifying the role of graph-based workflows in navigating NGS complexities. Real-world applications, from identifying functionally active variants across diverse populations to enhancing the discovery of Structural Variants (SV), will be showcased to illustrate GRAF's tangible impact. 

Beyond its broader applications, we'll focus on how GRAF can specifically elevate pharmaceutical research, addressing challenges in target identification and drug discovery.

Velsera Experts chatting

What you will learn in this webinar.

  • The significance of graph-based workflows in NGS data analysis.
  • Real-world applications and success stories demonstrating GRAF's impact on diverse genomic studies.
  • The enhanced discovery of functionally active variants, improved identification of structural variants, and accurate biomarker estimation.
  • The benefits of GRAF, including a ready-to-use, drop-in solution and compliance features.
  • Practical steps to initiate your drug discovery journey with GRAF.
  • An opportunity to engage in a Q&A session with experts to address your specific questions.

Meet the speaker: 

Dr. Steven Van Vooren, a seasoned expert in bioinformatics, AI, and Software Marketing, serves as Senior Director of Product Marketing at Velsera. With a background in molecular diagnostics from renowned institutions, including the Center for Human Genetics and the Sanger Institute, Steven is a versatile professional at the intersection of patient care, molecular biology, personalized medicine, software automation, and AI. As a founder and leader, he leverages a diverse skill set in AI/ML, clinical diagnostics, solution selling, product marketing, genomics, healthcare, and lab automation to drive innovation and growth. Steven excels in designing, building, and marketing transformative solutions across a spectrum of life sciences markets, contributing to Velsera's success by shaping the future of healthcare through visionary leadership and cutting-edge technologies.

Steven Van Vooren, PhD

Senior Director, Product Marketing at Velsera

Dr. Steven Van Vooren